Joint symptoms associated with anastrozole and letrozole in patients with breast cancer: a retrospective comparative study
Abstract Background Joint symptoms are a common side effect of aromatase inhibitors. However, it is not known if the risk of these symptoms varies between the members of this drug class. The aim of this study was to compare the frequency of joint symptoms associated with anastrozole and that associa...
Saved in:
Main Authors: | Yoshihito Morimoto (Author), Shuhei Sarumaru (Author), Yuko Oshima (Author), Chiho Tsuruta (Author), Kazuhiro Watanabe (Author) |
---|---|
Format: | Book |
Published: |
BMC,
2017-11-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Development and Validation of a Novel LC-MS/MS Method for the Simultaneous Determination of Abemaciclib, Palbociclib, Ribociclib, Anastrozole, Letrozole, and Fulvestrant in Plasma Samples: A Prerequisite for Personalized Breast Cancer Treatment
by: Lu Turković, et al.
Published: (2022) -
Estrone and Estradiol Levels in Breast Cancer Patients Using Anastrozole Are Not Related to Body Mass Index
by: Eduardo Borges Coscia, et al.
Published: (2017) -
Long-term efficacy and safety of anastrozole for adjuvant treatment of early breast cancer in postmenopausal women
by: Sharath Gangadhara, et al.
Published: (2009) -
Effects of psoralen on the pharmacokinetics of anastrozole in rats
by: Yuzhu Zhang, et al.
Published: (2018) -
Localized Cutaneous Adverse Event Induced by Anastrozole as Adjuvant Treatment for Breast Cancer: A Case Report
by: Aya Tanaka, et al.
Published: (2019)